| Document |
Document Title |
|
WO/2023/163461A1 |
The present specification relates to a structure of polymeric hyaluronic acid obtained by applying shear stress to a solution containing polymeric hyaluronic acid, a method for preparing same, and a cosmetic composition comprising same.
|
|
WO/2023/161373A1 |
Methods for pectin activation and pectin extraction, with high quality and efficiency, from plant-based materials that contain pectin are disclosed. A pectin-containing biomass material is first treated in hot, acidic aqueous alcohol wit...
|
|
WO/2023/162815A1 |
The purpose of the present invention is to provide a metal-organic framework having excellent gas adsorption ability. The present invention provides a metal-organic framework which comprises a metal ion and an organic ligand coordinated ...
|
|
WO/2023/163498A1 |
The present invention relates to a method for preparing a scratch-resistant bio-additive for plastics and a scratch-resistant additive for plastics prepared thereby and, more specifically, to a method for preparing a scratch-resistant bi...
|
|
WO/2023/159173A1 |
The present invention relates generally to resistant dextrins and methods of making resistant dextrins. In particular, the present invention relates to resistant dextrins having physical properties desirable in, at least, products for th...
|
|
WO/2023/156966A1 |
The present disclosure relates to compositions comprising mixtures of hydroxypropyl-β-cyclodextrin, wherein the compositions may be isomerically purified. The disclosure also relates to methods of isomerically purifying a mixture of hyd...
|
|
WO/2023/159172A1 |
The present invention relates generally to resistant dextrins and methods of making resistant dextrins. In particular, the present invention relates to resistant dextrins having physical properties desirable in, at least, products for th...
|
|
WO/2023/159175A1 |
The present invention relates generally to resistant dextrins and methods of making resistant dextrins. In particular, the present invention relates to resistant dextrins having physical properties desirable in, at least, products for th...
|
|
WO/2023/157150A1 |
[Problem] To provide an additional use of a polysaccharide derivative such as a tissue adhesive material. [Solution] According to some embodiments, a tissue adhesive material is provided, which is intended to be used for a hard and thick...
|
|
WO/2023/159171A1 |
The present invention relates generally to resistant dextrins and methods of making resistant dextrins. In particular, the present invention relates to resistant dextrins having physical properties desirable in, at least, products for th...
|
|
WO/2023/157924A1 |
The present invention relates to a complex-type sugar asparagine derived from an avian antibody and having a bisecting GlcNAc structure and a core fucose structure (wherein the Asn residue may be protected), and a method for producing th...
|
|
WO/2023/156349A1 |
The invention relates to sulfated chitosan derivatives of formula (I), wherein the meanings for the various substituents are as disclosed in the description, for their use in the treatment and/or prevention of a viral infection, particul...
|
|
WO/2023/153079A1 |
The present invention provides a production method for a β-1,3-glucan derivative suitable for reducing environmental load. The production method for a β-1,3-glucan derivative according to the present invention comprises performing an e...
|
|
WO/2023/154303A2 |
Described herein are di-phenylboronic acid (DiPBA) motifs that bind glucose with high affinity and improved specificity. The compounds can be used to prepare dynamic injectable materials with improved encapsulation and glucose-triggered ...
|
|
WO/2023/149402A1 |
The present invention provides a water-soluble chelating polymer which is capable of quickly trapping trace amounts of heavy metal ions and reducing the amount of the heavy metal ions to the ppm level or less in a short period of time.ã€...
|
|
WO/2023/148292A1 |
The invention relates to compositions having prebiotic and antipathogenic properties and use thereof for skin cosmetic purposes, such as regeneration and protection of the skin.
|
|
WO/2023/148619A1 |
Described are glycosaminoglycan (GAG) hydrogels with desirable gel properties and methods of producing GAGs with desirable gel properties, particularly hyaluronic acid hydrogels from non-animal origin hyaluronic acid. Further described a...
|
|
WO/2023/147150A1 |
Disclosed is a water-soluble biodegradable dispersant composition having a low to medium molecular weight carboxylated polysaccharide functionalized with at least one mono-valent (M+) cation and at least one di-valent (M++) cation and an...
|
|
WO/2023/138069A1 |
The present invention provides an apparatus for preparing chitosan oligosaccharide chelated ferrous iron, comprising first-stage mixing pipes, second-stage mixing pipes, and a mixing pool which are sequentially arranged from top to botto...
|
|
WO/2023/134202A1 |
The use of capsular polysaccharide A from Bacteroides fragilis and immune checkpoint inhibitors in preparation of drugs for treating digestive system tumors. The capsular polysaccharide from Bacteroides fragilis is capsular polysaccharid...
|
|
WO/2023/134207A1 |
Disclosed in the present invention is the use of combined medication of a zwitterionic capsular polysaccharide of Bacteroides fragilis and an immune checkpoint inhibitor in the prevention and treatment of genitourinary tumors. According ...
|
|
WO/2023/135135A1 |
The present invention relates to new hyaluronic acid derivatives conjugated with molecules of natural origin endowed with anti-inflammatory and/or antioxidant properties and processes for manufacturing the same. The covalent link of thes...
|
|
WO/2023/134206A1 |
Provided is a use of Bacteroides fragilis and/or a zwitterionic capsular polysaccharide thereof in the preparation of a drug for preventing and treating genitourinary system cancer. Bacteroides fragilis, especially Bacteroides fragilis Z...
|
|
WO/2023/137163A1 |
A process is disclosed for combining a polysaccharide ester polymer with one or more plasticizers in a way that produces a homogeneous blend. The polysaccharide ester polymer can be in the form of particles and fed to a heated extruding ...
|
|
WO/2023/134203A1 |
Disclosed is an application of bacteroides fragilis and/or a zwitterionic capsular polysaccharide thereof in the preparation of a drug for treating a respiratory system tumor. Bacteroides fragilis, and particularly bacteroides fragilis Z...
|
|
WO/2023/135229A1 |
The present invention relates to a polypeptide with at least 85% sequence identity to SEQ ID NO: 1, as an endo-ß-1,4-xylanase (EC 3.2.1.8) having transglycosylation activity. Preferably, said polypeptide is obtained from Rhamnusium bico...
|
|
WO/2023/134204A1 |
Disclosed is an application of zwitterionic capsular polysaccharide of Bacteroides fragilis combined with a PD-1 antibody and/or a PD-L1 antibody in the prevention and treatment of respiratory system tumors. According to the present inve...
|
|
WO/2023/134200A1 |
An application of bacteroides fragilis and/or a zwitterionic capsular polysaccharide thereof in the preparation of a drug for preventing and treating a digestive system tumor. A large number of experiments have proven that bacteroides fr...
|
|
WO/2023/132947A1 |
Substituted cyclodextrin complexes of closo-dodecaiodododecaborate and salts thereof are provided. Complexes according to certain embodiments are soluble in water sufficient to be used as an X-ray contrast agent. X-ray contrast agent com...
|
|
WO/2023/131355A1 |
The present invention relates to the technical field of antibacterial. Disclosed are a water-soluble chlorhexidine antibacterial, a preparation method therefor and an application thereof. In the present invention, the preparation method ...
|
|
WO/2023/133120A1 |
Interlocking porous hydrogel blocks (IPHB), which are suitable for variety of cell and/or tissue growth, are provided. The IPHBs have a three-dimensional (3D) macrostructure defined by a continuous polymeric matrix material and a network...
|
|
WO/2023/129738A2 |
Described herein are polysaccharide polymers comprising a saccharide moiety modified with a hydroxyl-modifying agent (e.g., a saccharide monomer of Formula (I)), as well as related compositions, hydrogels, implantable elements, and metho...
|
|
WO/2023/125790A1 |
Disclosed in the present invention are a cationized hyaluronic acid or a salt thereof, and a preparation method therefor. Carboxyl groups of the cationized hyaluronic acid or the salt thereof are at least partially linked to a quaternary...
|
|
WO/2023/129082A1 |
The present invention relates to the recovery and partial purification of the product formed in hyaluronic acid production fermentations without stopping the fermentation, thereby increasing the production efficiency and reusability of m...
|
|
WO/2023/125689A1 |
The present disclosure relates to glycosaminoglycan-collagen copolymer compositions (such as hyaluronic acid-collagen copolymers and heparosan-collagen copolymer compositions) and medical applications thereof for augmenting soft tissue d...
|
|
WO/2023/126576A1 |
According to an example aspect of the present invention, here is provided a polysaccharide ether grafted with poly(alkyl acrylate), a latex comprising a polysaccharide ether grafted with poly(alkyl acrylate), and a method of manufacturin...
|
|
WO/2023/129726A2 |
Described herein are polysaccharide polymers comprising a saccharide moiety modified with a hydroxyl-modifying agent (e.g., a saccharide monomer of Formula (I)), as well as related compositions, hydrogels, implantable elements, and metho...
|
|
WO/2023/125789A1 |
The present application provides a method for preparing calcium hyaluronate, the method comprising the following steps: adding sodium hyaluronate to an acidic displacement solution containing a calcium salt, and subjecting same to displa...
|
|
WO/2023/125957A1 |
The present application provides a preparation method for reduced hyaluronate. The method comprises the following steps: reacting sodium ascorbate with haloalkyl alcohol in water; and adding a hyaluronic acid or a salt thereof and an act...
|
|
WO/2023/120903A1 |
The present invention relates to a polymer with bovine serum albumin (BSA) conjugated to a polysaccharide therein, a preparation method therefor, an enzyme-stabilizing composition comprising same, and a method for amplification or detect...
|
|
WO/2023/117602A1 |
This invention deals with water-soluble graft polymers comprising as polymer base a polysaccharide, and as grafted side chains at least one water soluble ethylenically unsaturated monomer, such unsaturated monomer comprising at least one...
|
|
WO/2023/116142A1 |
A system and method for preparing erythritol and polydextrose from corn starch. The system comprises a pulp conditioning tank, a liquefying tank, a saccharifying tank, a filter, a first ion exchange system, a nanofiltration unit, a high-...
|
|
WO/2023/122542A1 |
Compositions comprising a reaction product of a saccharide polymer and a fatty acid or a fatty ester may be obtained in an aqueous phase in the presence of a hydroxide base and a neutral surfactant, the saccharide polymer comprising a de...
|
|
WO/2023/122288A2 |
The disclosure relates to methods for extracting an alginate biomass as well as related extract compositions. A biomass pulp is subjected to a multi-step or multi-stage extraction process including a first alkaline extraction followed by...
|
|
WO/2023/111140A1 |
The present invention lies in the technical field of drying an oligosaccharide. The present application discloses a method for drying an oligosaccharide or mixture of at least two oligosaccharides by using agitated thin film drying (ATFD...
|
|
WO/2023/114942A1 |
Compositions are disclosed herein comprising at least a solvent and an ether derivative of an alpha-glucan. Typically, (i) at least about 40% of the glycosidic linkages of the alpha-glucan are alpha-1,6 linkages, (ii) the alpha-glucan ha...
|
|
WO/2023/109990A1 |
The invention relates to a method of preparation of hyaluronic acid derivative, that has some carboxyl groups (-COOH) replaced by the primary hydroxyl group (-CH2-OH). The method of preparation is based on the carboxyl group activation u...
|
|
WO/2023/106275A1 |
Provided are wet-spun β-1,3-glucan fibers comprising β-1,3-glucan as the only constituent molecules, a method for producing the fibers, submicron fibrils, and a method for producing the submicron fibrils.　The wet-spun fibers comprise...
|
|
WO/2023/104059A1 |
Disclosed in the present invention are a circulating tumor cell detection material, detector and detection method. The circulating tumor cell detection material is fixed on a substrate. The detection material is a functionalized group mo...
|
|
WO/2023/105535A1 |
The present invention relates to photostable and room-temperature storable liquid compositions of sugammadex. The sugammadex liquid compositions comprise sugammadex and a vehicle, and have a dissolved oxygen content of less than about 3 ...
|
